Twinbeech Capital LP Pacira Bio Sciences, Inc. Transaction History

Twinbeech Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $776,322 - $959,290	-30,444 Reduced 35.94%	54,274 $1.55 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $2.35 Million - $3.01 Million	84,718 New	84,718 $2.48 Million
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $2.59 Million - $3.17 Million	-73,027 Reduced 66.52%	36,751 $1.5 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $4.19 Million - $6.31 Million	109,778 New	109,778 $4.24 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $547,820 - $614,593	-10,026 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $593,338 - $701,719	10,026 New	10,026 $608,000
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $178,613 - $234,494	-3,539 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $183,921 - $222,957	3,539 New	3,539 $213,000

260

49.8M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.1B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.